Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 1,047,557 | 223,486 | -824,071 | $86.00M | $14.57M | 63.94% | -$71.43M |
| Rallybio Corporation(RLYB) | 754,678 | 754,678 | 0 | $377.3K | $4.14M | 18.18% | +$3.76M |
| Kymera Therapeutics, Inc.(KYMR) | 457,059 | 19,648 | -437,411 | $25.86M | $1.53M | 6.71% | -$24.34M |
| Seer, Inc.CL A(SEER) | 816,375 | 816,375 | 0 | $1.80M | $1.49M | 6.56% | -$310.2K |
| Xilio Therapeutics, Inc.(XLO) | 667,742 | 667,742 | 0 | $595.6K | $427.5K | 1.88% | -$168.1K |
| Rapt Therapeutics Inc | 12,437 | 12,437 | 0 | $320.8K | $421.2K | 1.85% | +$100.5K |
| Sutro Biopharma, Inc.(STRO) | 175,000 | 17,500 | -157,500 | $153.1K | $202.5K | 0.89% | +$49.4K |